Syensqo bolsters biotech position with ceramides acquisition

0
548

In Belgium, Syensqo has completed the acquisition of South Korean ceramides specialist JinYoung Bio, a move that expands the Syensqo’s beauty care portfolio.

“This acquisition reflects our deep commitment to innovation and our focus on sustainable solutions leveraging the power of biotechnology. We are dedicated to making a meaningful impact in the beauty industry, addressing critical environmental and societal challenges with groundbreaking circular solutions, Ilham Kadri, CEO of Syensqo, said in a press statement.

The addition of JinYoung Bio’s technology will extend Syensqo’s product portfolio into biomimetic ceramides for skin care and hair care applications, as well as a range of biobased functional ingredients used in skin care and color cosmetic applications. Ceramides are produced through biotechnology via a fermentation process, which aligns with the focus of Syensqo’s Renewable Materials and Biotechnology Growth Platform.